Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

01-12-2021 | Ciprofloxacin | Research article

Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi

Authors: Pizga Kumwenda, Emmanuel C. Adukwu, Ebot S. Tabe, Victor. C. Ujor, Pocha S. Kamudumuli, Maono Ngwira, Joseph Tsung Shu Wu, Master R. O. Chisale

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Bacterial infections are a significant cause of sickness and death in sub-Saharan Africa. This study aimed at establishing the prevalence, distribution and antimicrobial susceptibility pattern of major bacterial isolates from patients accessing medical care at a tertiary hospital in Malawi.

Methods

We retrospectively reviewed bacteria culture and antimicrobial susceptibility records for 4617 patients from 2002 to 2014 at Mzuzu Central Hospital (MCH). No inclusion and exclusion criteria were followed. Data was analysed using excel (Microsoft office, USA) and GraphPad prism 7 software programs.

Results

The most prevalent isolates were S. aureus (34.7%, n = 783), Klebsiella species (17.4%, n = 393) and Proteus species (11.4%, n = 256). Most microorganisms were isolated from adults (88.3%, n = 3889) and pus was the main source (69.3%, n = 1224). S. pneumoniae was predominantly isolated from cerebrospinal fluid (60.3%, n = 44) largely collected from children (88.2%, n = 64). Overall, most bacteria exhibited high resistance to all regularly used antimicrobials excluding ciprofloxacin.

Conclusions

Our report demonstrates an increase in bacterial infection burden in sites other than blood stream and subsequent increase in prevalence of antimicrobial resistance for all major isolates. Creating an epidemiological survey unit at MCH will be essential to help inform better treatment and management options for patients with bacterial infections.
Literature
1.
go back to reference Troeger C, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191–210.CrossRef Troeger C, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191–210.CrossRef
2.
go back to reference WHO. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva: World Health Organization; 2016. WHO. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva: World Health Organization; 2016.
3.
go back to reference Byarugaba D. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24(2):105–10.PubMedCrossRef Byarugaba D. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24(2):105–10.PubMedCrossRef
5.
go back to reference Musicha P, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042–52.PubMedPubMedCentralCrossRef Musicha P, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042–52.PubMedPubMedCentralCrossRef
6.
go back to reference Mbanga J, Dube S, Munyanduki H. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo province, Zimbabwe. East Afr J Public Health. 2010;7(3):229–32. Mbanga J, Dube S, Munyanduki H. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo province, Zimbabwe. East Afr J Public Health. 2010;7(3):229–32.
7.
go back to reference Attram N, et al. Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015. PLoS One. 2019;14(10):e0223598.PubMedPubMedCentralCrossRef Attram N, et al. Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015. PLoS One. 2019;14(10):e0223598.PubMedPubMedCentralCrossRef
9.
10.
go back to reference Cheesbrough M. District laboratory practice in tropical countries. Tropical Health Technology, Norfolk: Cambridge university press; 2006. Cheesbrough M. District laboratory practice in tropical countries. Tropical Health Technology, Norfolk: Cambridge university press; 2006.
11.
go back to reference Daoud Z, et al. Escherichia coli isolated from urinary tract infections of Lebanese patients between 2005 and 2012: epidemiology and profiles of resistance. Front Med. 2015;2:26. Daoud Z, et al. Escherichia coli isolated from urinary tract infections of Lebanese patients between 2005 and 2012: epidemiology and profiles of resistance. Front Med. 2015;2:26.
12.
go back to reference CLSI. Performance standards for antimicrobial susceptibility testing. In: Twenty-Second Informational Supplement ed, vol. 32. Wayne, PA: Clinical and Laboratory Standard Institute, CLSI document M100-S22; 2012. CLSI. Performance standards for antimicrobial susceptibility testing. In: Twenty-Second Informational Supplement ed, vol. 32. Wayne, PA: Clinical and Laboratory Standard Institute, CLSI document M100-S22; 2012.
13.
go back to reference Feasey NA, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L, et al. A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out. PLoS One. 2014;9(3):e92226. Feasey NA, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L, et al. A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out. PLoS One. 2014;9(3):e92226.
14.
15.
go back to reference Iroh Tam P-Y, et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998–2017). Clin Infect Dis. 2019;69(1):61–8.PubMedCrossRef Iroh Tam P-Y, et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998–2017). Clin Infect Dis. 2019;69(1):61–8.PubMedCrossRef
16.
go back to reference Archibald LK, et al. Epidemiology of bloodstream infections in a bacille Calmette-Guerin-vaccinated pediatric population in Malawi. J Infect Dis. 2003;188(2):202–8.PubMedCrossRef Archibald LK, et al. Epidemiology of bloodstream infections in a bacille Calmette-Guerin-vaccinated pediatric population in Malawi. J Infect Dis. 2003;188(2):202–8.PubMedCrossRef
17.
go back to reference Peters RP, et al. A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Tropical Med Int Health. 2004;9(8):928–34.CrossRef Peters RP, et al. A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Tropical Med Int Health. 2004;9(8):928–34.CrossRef
18.
go back to reference NORTON EB, et al. Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. Pediatr Infect Dis J. 2004;23(2):145–51.PubMedCrossRef NORTON EB, et al. Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. Pediatr Infect Dis J. 2004;23(2):145–51.PubMedCrossRef
20.
go back to reference Komolafe O, et al. Bacteriology of burns at the queen elizabeth central hospital, Blantyre, Malawi. Burns. 2003;29(3):235–8.PubMedCrossRef Komolafe O, et al. Bacteriology of burns at the queen elizabeth central hospital, Blantyre, Malawi. Burns. 2003;29(3):235–8.PubMedCrossRef
21.
go back to reference Maina D, Omuse G, Gunturu Revathi RDA. Spectrum of microbial diseases and resistance patterns at a private teaching hospital in Kenya: implications for clinical practice. PLoS One. 2016;11(1):e0147659. Maina D, Omuse G, Gunturu Revathi RDA. Spectrum of microbial diseases and resistance patterns at a private teaching hospital in Kenya: implications for clinical practice. PLoS One. 2016;11(1):e0147659.
22.
go back to reference Okesola A, Kehinde A. Bacteriology of non-surgical wound infections in Ibadan, Nigeria. Afr J Med Med Sci. 2008;37(3):261–4.PubMed Okesola A, Kehinde A. Bacteriology of non-surgical wound infections in Ibadan, Nigeria. Afr J Med Med Sci. 2008;37(3):261–4.PubMed
23.
go back to reference Biadglegne F, Abera B, Alem A, Anagaw B. Bacterial isolates from wound infection and their antimicrobial susceptibility pattern in Felege Hiwot referral Hospital North West Ethiopia. Ethiop J Health Sci. 2009;19(3):1029–857. Biadglegne F, Abera B, Alem A, Anagaw B. Bacterial isolates from wound infection and their antimicrobial susceptibility pattern in Felege Hiwot referral Hospital North West Ethiopia. Ethiop J Health Sci. 2009;19(3):1029–857.
24.
go back to reference Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):756.PubMedPubMedCentralCrossRef Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):756.PubMedPubMedCentralCrossRef
25.
go back to reference Tong SY, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.PubMedPubMedCentralCrossRef Tong SY, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.PubMedPubMedCentralCrossRef
26.
go back to reference Rennie RP, et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY antimicrobial surveillance program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003;45(4):287–93.PubMedCrossRef Rennie RP, et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY antimicrobial surveillance program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003;45(4):287–93.PubMedCrossRef
27.
go back to reference Mordi R, Momoh M. Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. Afr J Biotechnol. 2009;8(5):1684–5315. Mordi R, Momoh M. Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. Afr J Biotechnol. 2009;8(5):1684–5315.
28.
go back to reference Perween N, Prakash SK, Siddiqui O. Multi drug resistant Klebsiella isolates in burn patients: a comparative study. J Clin Diagn Res. 2015;9(9):DC14.PubMedPubMedCentral Perween N, Prakash SK, Siddiqui O. Multi drug resistant Klebsiella isolates in burn patients: a comparative study. J Clin Diagn Res. 2015;9(9):DC14.PubMedPubMedCentral
29.
go back to reference Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PloS one. 2018;13(6):e0198772. Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PloS one. 2018;13(6):e0198772.
30.
go back to reference Mandomando I, et al. Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique. Am J Trop Med Hyg. 2010;83(1):152–7.PubMedPubMedCentralCrossRef Mandomando I, et al. Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique. Am J Trop Med Hyg. 2010;83(1):152–7.PubMedPubMedCentralCrossRef
32.
go back to reference Gordon SB, et al. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis. 2000;31(1):53–7.PubMedCrossRef Gordon SB, et al. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis. 2000;31(1):53–7.PubMedCrossRef
33.
go back to reference Carrol ED, et al. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J. 2007;26(5):416.PubMedPubMedCentralCrossRef Carrol ED, et al. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J. 2007;26(5):416.PubMedPubMedCentralCrossRef
34.
go back to reference Molyneux E, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360(9328):211–8.PubMedCrossRef Molyneux E, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360(9328):211–8.PubMedCrossRef
35.
go back to reference Gordon SB, et al. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS (London, England). 2002;16(10):1409.CrossRef Gordon SB, et al. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS (London, England). 2002;16(10):1409.CrossRef
36.
go back to reference Tseng W-P, et al. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;7(1):93.PubMedPubMedCentralCrossRef Tseng W-P, et al. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;7(1):93.PubMedPubMedCentralCrossRef
37.
go back to reference Health, M.M.o, Malawi Standard Treatment Guidelines. 2015. Health, M.M.o, Malawi Standard Treatment Guidelines. 2015.
Metadata
Title
Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi
Authors
Pizga Kumwenda
Emmanuel C. Adukwu
Ebot S. Tabe
Victor. C. Ujor
Pocha S. Kamudumuli
Maono Ngwira
Joseph Tsung Shu Wu
Master R. O. Chisale
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05725-w

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue